Results 131 to 140 of about 40,729 (298)

Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects

British Journal of Clinical Pharmacology, EarlyView.
Aims Oral administration of (S)‐ketamine for treatment‐resistant depression (TRD), as alternative to the registered intranasal or off‐label intravenous administrations, has high potential. However, it is characterized by an extensive first‐pass metabolism, resulting in low (S)‐ketamine exposure and high levels of active metabolites, including (S ...
Marije E. Otto, Gabriël E. Jacobs, Joost C. van Mechelen, Laura G. J. M. Borghans, Johan G. C. van Hasselt, Linda B. S. Aulin   +5 more
wiley   +1 more source

Investigating the Pleiotropic Role of KIF21B in Schizophrenia and Multiple Sclerosis: A Bioinformatics Analysis. [PDF]

Clin Neuropsychiatry
Korkmaz ED, Everest E.
europepmc   +1 more source

Family caregivers' burden and coping strategies with clients living with schizophrenia in neuropsychiatry specialist hospital in Akure, Ondo state, Nigeria

, 2022
O.S. Bolarinwa, F.O. Kehinde
openalex   +2 more sources

Clinical Neuropsychiatry

Focus, 2016
Margo, Lauterbach, Sheldon, Benjamin
openaire   +3 more sources

Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies

British Journal of Clinical Pharmacology, EarlyView.
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria, Annisa Lazuardi Larasati, Indri Yuliani Hamdani, Jin‐Gun Cho, Jan‐Willem C. Alffenaar   +4 more
wiley   +1 more source

Optimising Mental Health Care for People With Neurological Conditions in the UK: Evidence-Based Models for Integrated Neuropsychiatric Services. [PDF]

Cureus
Asim N, Miah AMO.
europepmc   +1 more source

Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen, Anna‐Maija Tolppanen, Valtteri Kaasinen, Marjaana Koponen, Sirpa Hartikainen   +4 more
wiley   +1 more source

Fear-themed digital media exposure and sleep regulatory sensitivity in school-aged children: preliminary observations toward a developmental PhenoSleep construct. [PDF]

Front Neurol
Gnazzo M, Bargiacchi G, Germanò E, Maltese A, Parisi L, Firrigno L, Roccella M, Spoto G, Rosa GD, Scifo L, Gallai B, Testa D, Terracciano AM, Carotenuto M.   +13 more
europepmc   +1 more source

Neuropsychiatry in World War II: Vol. I—Zone of Interior.

, 1969
Michael Shepherd
openalex   +1 more source

There is nothing to fear but the amygdala: applying advances in the neuropsychiatry of fear to public policy [PDF]

, 2014
Lawrence Amsel, Spencer Harbo, Amitai Halberstam   +2 more
openalex   +1 more source